Chinese Journal of Clinical Pharmacology and Therapeutics ›› 1999, Vol. 4 ›› Issue (4): 286-291.
Previous Articles Next Articles
ZHANG Shou-Lan, LIN Fu-Sheng, YU Lin, LIU Min
Received:
1999-03-25
Revised:
1999-09-20
Published:
2020-11-27
CLC Number:
ZHANG Shou-Lan, LIN Fu-Sheng, YU Lin, LIU Min. Kinetic study of nicotinic acetycholine rceptor[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1999, 4(4): 286-291.
1 金期局,主编.分子药理学,1990:315 天津科学出版社出版,1990:315 2 宋杰军,毛庆武.海洋生物毒素学, 1997:79 3 徐叔云,卞如濂,陈修,主编 药理实验方法学,人民卫生出版社, 1990:349 4 Kobayashi J, Ohizumi Y,Nakamura H,et al.Pharmacologicalstudy on the venom of the marinesnail conus textile Toxicon,1981;9(6):756 5 Kobayashi J,Nakamura H, Ohizumi Y.Potent excitatory effects of a cardiotonic protein from the venom of the marine snail conus magus on the guinea-pig left atria,vas deferens and ileum Toxicon,1985;23(5):783 6 Williarm R.Lonotoxin GF:Disulfide Bridges, Synthesis,and preparation of Iodinated Derivatives Biochem.1984 ;23(5):2796 7 Lourdes J.Conus venons:A rich source of neuroactive peptides Toxicon-Toxin Reviews 1985;4(2):107 8 Bradley G.Acetylcholine receptor Binding characteristics of snake and cone snailve nom post synaptic neurotoxins:further studies with a nonradioactive assay Toxin.1993;31(9):825 9 Richard A.Conus peptides as chemical probes for Receptors and Jon channels 1993;93(5):1923 10 Hans Jurgen Kreienkamp.Glycosylation sites selectively Interfere with a-toxin binding to the nicotinic acetylcholine receptor.J Bio chem 1994;269(11):8108 11 Maelicke A Acetylcholine Receptor J Bio chem, 1997;252(14):4811 12 Ging Kuo Wang.Ligand Responses of a-Bungaro toxin binding sites from slceletal muscle and optic lobe of the chick, J Bio chem,1978 ;253(23):8507 13 Bianca M.Nonequivalence of a-Bung arotoxin binding sites in the nitive nicotinic receptor molecule Biochem,1990;29:1046 14 Bianca M.Brain and muscle nicotinicacetylcholine receptors are different but homolgous proteins.Proc Natl Acad Sci USA 1985;82:5208 |
[1] | CAO Xuefen, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, LYU Xingjiao, Janvier NIBARUTA. Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1201-1208. |
[2] | WANG Jian, SUN Yongdong, ZHOU Xingwei, LIU Lei, CHEN Long, TONG Xingke, ZHU Jiali. Baicalein promotes laryngeal cancer cell death and inhibits invasion via miR-125b-5p/IRF4 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1209-1218. |
[3] | ZHU Ruifang, GUO Dongkai, ZHI Hui, JIANG Yiguo, ZHANG Yueling, QIAN Xiaoping, JI Shiliang. Exploring the mechanism of elemene synergistic bortezomib against multiple myeloma by ROS-NF-κB-p38MAPK pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1219-1226. |
[4] | LI Fei, DING Huiqin, CHEN Mengjing. Isonlosinine induces autophagy of PC9 cells by ERK signaling pathway in lung cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1235-1240. |
[5] | SHI Dandan, SUN Yiyao, CHEN Xiaoqi, YANG Fangming, ZHANG Chuanlei, WANG Xinting, YUAN Changwei, CHEN Xinju. Curative effect of fuzheng xiaoliu granules in the treatment of primary liver cancer and analysis of serum metabolomics [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1247-1262. |
[6] | CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke. Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092. |
[7] | WANG Xiu, JI Qilin, PEI Wenjun, ZENG Ying. 3-bromopyruvate cholesterol ester enhances the sensitivity of breast cancer cells to tamoxifen [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1093-1100. |
[8] | HENG Bingbing, YANG Danfeng, DAI Shuyang, SHANGGUAN Wangning. Propofol relieves the subcutaneous chloroquine-induced pruritus in rats via TRPV1 and CB1 receptors of spinal cord [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1101-1108. |
[9] | LIAO Mengling, WANG Yan, LUO Jing, WANG Nuoyan, HUA Ling, ZHANG Yu, DENG Fei, YUAN Yue, ZHOU Jun, ZHOU Hong. Molecular mechanism of artesunate attenuates the release of proinflammatory cytokines from macrophages [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 969-978. |
[10] | YOU Rongli, HUANG Yurong, MAORui, HAI Lina, WANG Yingli, WANG Yan. Mechanism of compound kushen injection in the treatment of lung cancer based on serum metabolomics and network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 988-999. |
[11] | WANG Ruyue, XIE Fei, WANG Xin, LI Hongyu. Therapeutic effect of lienal polypeptide injection on bone marrow suppression and immunodeficiency in KM mice following chemotherapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1000-1007. |
[12] | MAO Jun, RONG Yu, LI Yangen, XIONG Dengxi, ZHAO Peng, ZHA Zhengjiang. Effect and safety of flurbiprofen axetil in the analgesic treatment of patients with craniocerebral injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1056-1060. |
[13] | MA Xiankang, YANG Lixia, CUI Yangyang, MI Denghai. Angelica polysaccharides improve hepatic endoplasmic reticulum stress by inhibiting the expression of GRP78, p-PERK and p-Eif2α in diabetic KK-Ay mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 926-936. |
[14] | WANG Kun, XU Peipei, ZHOU Lanlan, LU Sheng. Mechanism of neuroprotective effect of ginsenoside Rg1 regulating Epac1/Rap1 signaling pathway in rats with ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 721-727. |
[15] | LI Shixu, LI Linyun, WANG Xin, LI Ke, BIAN Hua. Effects of Ginkgo biloba extract on renal injury in rats with experimental renal failure through miR-145/FOXO1 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 728-735. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||